Clinical Trials Logo

Actinic Cheilitis clinical trials

View clinical trials related to Actinic Cheilitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02409732 Completed - Actinic Cheilitis Clinical Trials

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

Start date: April 2015
Phase: Phase 4
Study type: Interventional

To evaluate the safety and efficacy of PDT with blue light and topical Levulan in the treatment of actinic cheilitis.

NCT ID: NCT02198469 Completed - Actinic Cheilitis Clinical Trials

Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis

Start date: January 2012
Phase: Phase 1
Study type: Interventional

Methyl aminolaevulinate photodynamic therapy (MAL-PDT) is advantageous in that it has few cosmetic side effects and minimises patient discomfort. However, its relatively low efficacy prevents its application to the treatment of actinic cheilitis(AC). Er:YAG ablative fractional laser (AFL) treatment removes the stratum corneum to increase MAL uptake and may improve efficacy. However, no studies have directly compared the efficacy of MAL-PDT with and without Er:YAG AFL in treating AC

NCT ID: NCT00868088 Completed - Actinic Cheilitis Clinical Trials

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

Start date: July 2009
Phase: Phase 4
Study type: Interventional

Our study is designed to evaluate the efficacy of photodynamic therapy (PDT) for treatment of actinic cheilitis (AC) and as an adjunct to Mohs surgery for squamous cell carcinoma (SCC) on the lips. This study will utilize an FDA approved PDT modality (DUSA, Inc., Wilmington, MA 01887) using topical 5-amino-levulinic acid (ALA) for photosensitization followed by exposure to a Blu-U light source emitting 405-420nm wavelength light.

NCT ID: NCT00849992 Completed - Actinic Cheilitis Clinical Trials

Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy

Start date: March 2009
Phase: Phase 4
Study type: Interventional

Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.